Global Pharmaceutical Plastic Bottles Market

Report ID : 1284 | Published : 2022-07-04 | Pages: | Format: PDF/EXCEL

The Global Pharmaceutical Plastic Bottles Market is estimated to reach over USD 11.44 billion by 2030, exhibiting a CAGR of 5.6% during the forecast period.

The demand for plastic packaging has witnessed a large increase in the pharmaceutical industry due to its unrivaled ability. Barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, heat and flame resistance, and extension of expiry dates are other features that have led to increased adoption in pharma. The market for pharmaceutical plastic bottles is expanding due to rising sustainability concerns, which are being addressed by increasing recycling rates and reducing the pharmaceutical industry's environmental impact. Technological advancements and the increasing use of plastic bottles in solid and even liquid oral medicines have contributed to the growth of the pharmaceutical plastic bottle market. Increased use of dietary supplements and other healthcare products is also driving demand for pharmaceutical plastic bottles, which is expected to drive the target market's growth.

However, growing concerns about the use of plastics due to their negative impact on the environment are driving consumers to reduce their use, which may limit the target market's growth to some extent. Furthermore, one of the factors impeding the development of the global pharmaceutical plastic bottle market is stringent government plastic regulations.

Market Segmentation:

The global pharmaceutical plastic bottle market is segmented based on bottle types, material types, and capacity. Based on bottle types, the market is segmented as plastic bottles for the solid formulation, plastic bottles for liquid, and plastic bottles for ophthalmic/nasal formulation. The other material types segment includes polyethylene (PE), high-density polyethylene (HDPE), low-density polyethylene (LDPE), polyethylene terephthalate (PET), polypropylene (PP), and polyvinyl chloride (PVC). By capacity, the market is segmented into below 100 ml, 100 ml – 250 ml, and above 250 ml.

Based on material types, the high-density polyethylene (HDPE) segment is accounted as a major contributor to the pharmaceutical plastic bottles market

The high-density polyethylene (HDPE) category is expected to hold a major share in the global pharmaceutical plastic bottle market in 2021. This is attributed to the growing usage of high-density polyethylene (HDPE) in manufacturing pharmaceutical plastic bottles. HDPE is operated to make a variety of bottles, including un-pigmented bottles, which are translucent and have excellent stiffness and barrier properties. According to Plastics Europe, a report published by an association of European plastic manufacturers in December 2020, the consumption of HDPE in Europe in 2019 was around 6.5 million tons. HDPE is also commonly used in the commercial sector for larger containers due to its high strength-to-weight ratio and lower brittleness than PP. It keeps its lightweight nature when molded, making it suitable for larger containers such as plastic canisters. The new barrier resin technology uses less resin to mold and craft high-density polyethylene (HDPE) bottles while maintaining barrier protection properties.

Plastic Bottles for the Ophthalmic/Nasal Formulation segment witnessed growth at a rapid rate.

Plastic bottles for the ophthalmic/nasal formulations have emerged as the leading contributors to the growth of the global pharmaceutical plastic bottles market, based on bottle types of segment. The increased use of corticosteroid drugs in nasal formulations for a variety of treatments is increasing consumption. Moreover, the growing problem of pollution-related eye allergies is a significant factor driving up demand.

In the region, the North American pharmaceutical plastic bottles market holds a significant revenue share.

The North American pharmaceutical plastic bottles market is expected to register the highest market share in terms of revenue during the forecast period. The market for plastic bottles in the United States is expected to increase substantially due to rising consumption and industrial applications of plastic-made containers and bottles. Plastic projects are expected to increase across various products and industries, including beverage, food and water, pharmaceutical, and household. According to Pharmaceutical Commerce, the pharmaceutical market in the United States is expanding. Americans are expected to spend USD 635 to USD 655 billion on pharmaceuticals by 2023. In comparison to 2019, this represents a solid 29.6–33.7% increase in spending in 2020. As a result, it is almost certain that it will be the country with the highest pharmaceutical expenditure. In addition, Asia Pacific is projected to grow at a rapid rate in the global pharmaceutical plastic bottles market owing to the strong presence of manufacturing industries. Besides that, lower labour costs and easy access to raw materials are also expected to drive the region's target market growth. China is one of Asia's largest pharmaceutical markets, making it profitable for manufacturers of pharmaceutical plastic bottles.

Competitive Landscape

Major key players in the global pharmaceutical plastic bottles market are Berry Global Inc., Amcor plc., Schott AG, West Pharmaceutical Services Inc., Gerresheimer AG, AptarGroup Inc., Nipro Corporation, Becton, Dickinson, WestRock Company, and Catalent Inc.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Pharmaceutical Plastic Bottles Market Snapshot

Chapter 4. Global Pharmaceutical Plastic Bottles Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Key Trends in the Market

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. COVID 19 Impact Analysis

Chapter 5. Pharmaceutical Plastic Bottles Market Segmentation 1: By Types Estimates & Trend Analysis

5.1. By Bottle Types & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Bottle Types:

5.2.1. Plastic Bottles for Solid Formulation

5.2.2. Plastic Bottles for Liquid

5.2.3. Plastic Bottles for Ophthalmic/Nasal Formulation

Chapter 6. Pharmaceutical Plastic Bottles Market Segmentation 2: By Material Types Estimates & Trend Analysis

6.1. By Material Types & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Material Types:

6.2.1. Polyethylene (PE)

6.2.2. High-density polyethylene (HDPE)

6.2.3. Low-density polyethylene (LDPE)

6.2.4. Polyethylene terephthalate (PET)

6.2.5. Polypropylene (PP)

6.2.6. Polyvinyl chloride (PVC)

Chapter 7. Pharmaceutical Plastic Bottles Market Segmentation 4: By Capacity Estimates & Trend Analysis

7.1. By Capacity Analysis & Market Share, 2020 & 2030

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Capacity:

7.2.1. Below 100 ml

7.2.2. 100 ml – 250 ml

7.2.3. Above 250 ml

Chapter 8. Pharmaceutical Plastic Bottles Market Segmentation 5: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Bottle Types, 2020-2030

8.1.2. North America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Material Types, 2020-2030

8.1.3. North America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Capacity, 2020-2030

8.1.4. North America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Bottle Types, 2020-2030

8.2.2. Europe Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Material Types, 2020-2030

8.2.3. Europe Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Capacity, 2020-2030

8.2.4. Europe Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Bottle Types, 2020-2030

8.3.2. Asia Pacific Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Material Types, 2020-2030

8.3.3. Asia Pacific Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Capacity, 2020-2030

8.3.4. Asia Pacific Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Bottle Types, (US$ Million) 2020-2030

8.4.2. Latin America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Material Types, 2020-2030

8.4.3. Latin America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Capacity, (US$ Million) 2020-2030

8.4.4. Latin America Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA revenue Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Bottle Types, (US$ Million) 2020-2030

8.5.2. MEA Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Material Types, 2020-2030

8.5.3. MEA revenue Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) By Capacity, (US$ Million) 2020-2030

8.5.4. MEA revenue Pharmaceutical Plastic Bottles Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2020-2030

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Berry Global Inc.

9.2.2. Amcor Plc

9.2.3. Gerresheimer AG

9.2.4. AptarGroup, Inc

9.2.5. O. Berk Company, LLC.

9.2.6. Alpha Packaging Holdings, Inc.

9.2.7. COMAR, LLC

9.2.8. Alpack Inc.

9.2.9. Drug Plastics Group

9.2.10. ALPLA Werke Alwin Lehner GmbH & Co KG

9.2.11. Pont Europe Limited

9.2.12. Bormioli Pharma S.p.a.

9.2.13. C.L.Smith Company

9.2.14. United States Plastic Corporation

9.2.15. Weener Plastics Group BV

9.2.16. Origin Pharma Packaging

9.2.17. Pretium Packaging Corporation

9.2.18. Pro-Pac Packaging Group Pty Ltd

8.3. List of Other Prominent Players

Segmentation of Global Pharmaceutical Plastic Bottles Market -

By Bottle Types -

  • Plastic Bottles for Solid Formulation
  • Plastic Bottles for Liquid
  • Plastic Bottles for Ophthalmic/Nasal Formulation

By Material Types -

  • Polyethylene (PE)
  • High-density polyethylene (HDPE)
  • Low-density polyethylene (LDPE)
  • Polyethylene terephthalate (PET)
  • Polypropylene (PP)
  • Polyvinyl chloride (PVC)

By Capacity -

  • Below 100 ml
  • 100 ml – 250 ml
  • Above 250 ml

By Region -

North America -

  • The U.S.
  • Canada
  • Mexico

Europe -

  • Germany
  • The U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific -

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America -

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa -

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Pharmaceutical Plastic Bottles Market?

Market is estimated to reach over USD 11.44 billion by 2030

exhibiting a CAGR of 5.6% during the forecast period.

Our Clients